News
News
- Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
02/25/2021 / 20:53 - GlobeNewswire - Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
02/25/2021 / 12:45 - GlobeNewswire - Genmab announces initiation of share buy-back program
02/23/2021 / 17:05 - GlobeNewswire - Genmab Publishes 2020 Annual Report
02/23/2021 / 17:00 - GlobeNewswire - Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines
02/22/2021 / 14:00 - GlobeNewswire - Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA
02/19/2021 / 13:07 - GlobeNewswire - Pfizer and BioNTech Commence Global Clinical Trial to Evaluate COVID-19 Vaccine in Pregnant Women
02/18/2021 / 19:30 - GlobeNewswire - In Vitro Study Published in The New England Journal of Medicine Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations
02/17/2021 / 23:13 - GlobeNewswire - Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
02/17/2021 / 10:00 - GlobeNewswire - Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
02/12/2021 / 14:30 - GlobeNewswire
Real-time